StockData
Cogent Biosciences, Inc. logo

Cogent Biosciences, Inc. (COGT) stock

COGTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 2/30
$27.81−0.04 (-0.14%)

Close on Nov 18, 2026Market cap $4.83BP/E –Yield –

Cogent Biosciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Cogent Biosciences's market cap was $5.04B on Nov 11, 2026, against $5.62B a year earlier. Over the last 5 years it ranged from $211.23M to $6.65B, with a median of $896.91M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$5.04B+1.6%
2025Dec 31, 2025$4.97B+476.5%
2024Dec 31, 2024$861.57M+70.1%
2023Dec 29, 2023$506.41M-37.3%
2022Dec 30, 2022$807.56M+136.2%
2021Dec 31, 2021$341.92M+185.2%
2020Dec 31, 2020$119.91M+443.0%
2019Dec 31, 2019$22.08M-83.2%
2018Dec 31, 2018$131.67M–

More Cogent Biosciences figures

See a number that looks wrong?